Why Corporate Travel Management, Kingsgate, Liontown, and Neuren shares are racing higher

These ASX shares are ending the week on a positive note.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a small gain. In afternoon trade, the benchmark index is up 0.2% to 6,978.3 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are rising:

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

Corporate Travel Management Ltd (ASX: CTD)

The Corporate Travel Management share price is up almost 4% to $17.37. This may have been driven by a broker note out of Morgan Stanley. It has retained its overweight rating and $28.00 price target. The broker feels the market is being too negative and believes the company can achieve its guidance in FY 2023.

Kingsgate Consolidated Limited (ASX: KCN)

The Kingsgate share price has jumped 17% to $1.77. Investors have been buying this gold miner's shares after it announced the official reopening of its Chatree mine in Thailand. This follows the granting of approval from the Department of Primary Industries and Mines. Management described it as "a truly remarkable moment."

Liontown Resources Ltd (ASX: LTR)

The Liontown share price is up 4% to $1.59. This is despite there being no news out of the lithium developer. However, it is worth noting that a number of lithium shares are climbing today. Some investors may believe a buying opportunity has opened up following heavy declines in recent sessions.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is up a further 8% to $13.40. This biotech company's shares have been on fire this week thanks to news that its treatment for Rett's Syndrome has been granted US FDA approval. This is the first and only approved treatment for the rare genetic neurological and developmental disorder that affects the way the brain develops. It is expected to be available by the end of April 2023.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough end to a rough week for investors.

Read more »

A girl sits on her bed in her room while using laptop and listening to headphones.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another rough ride for investors this Thursday.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Wednesday that left investors wanting today.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back to the races this Tuesday.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre start to the trading week this Monday.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

This ASX 200 stock turned $5,000 into $31,960 in just 1 year. Here's how

Investors have sent this ASX 200 stock rocketing 539% in 12 months. But why?

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lukewarm end to a stunning trading week today.

Read more »

Smiling woman pointing at rising graph.
Share Gainers

Here are the top 10 ASX 200 shares today

Records tumbled this Thursday.

Read more »